JP2006512894A5 - - Google Patents

Download PDF

Info

Publication number
JP2006512894A5
JP2006512894A5 JP2004511349A JP2004511349A JP2006512894A5 JP 2006512894 A5 JP2006512894 A5 JP 2006512894A5 JP 2004511349 A JP2004511349 A JP 2004511349A JP 2004511349 A JP2004511349 A JP 2004511349A JP 2006512894 A5 JP2006512894 A5 JP 2006512894A5
Authority
JP
Japan
Prior art keywords
fusion protein
pharmaceutical composition
homodimeric
nucleic acid
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004511349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512894A (ja
JP4722480B2 (ja
Filing date
Publication date
Priority claimed from EP02012742A external-priority patent/EP1369128A1/en
Application filed filed Critical
Publication of JP2006512894A publication Critical patent/JP2006512894A/ja
Publication of JP2006512894A5 publication Critical patent/JP2006512894A5/ja
Application granted granted Critical
Publication of JP4722480B2 publication Critical patent/JP4722480B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004511349A 2002-06-07 2003-06-05 糖タンパク質viドメインを含むイムノアドヘシン Expired - Lifetime JP4722480B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02012742.9 2002-06-07
EP02012742A EP1369128A1 (en) 2002-06-07 2002-06-07 Inhibitors of glycoprotein VI and their therapeutic use
PCT/EP2003/005929 WO2003104282A2 (en) 2002-06-07 2003-06-05 Immunoadhesin comprising a glycoprotein vi domain

Publications (3)

Publication Number Publication Date
JP2006512894A JP2006512894A (ja) 2006-04-20
JP2006512894A5 true JP2006512894A5 (https=) 2006-07-06
JP4722480B2 JP4722480B2 (ja) 2011-07-13

Family

ID=29433140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004511349A Expired - Lifetime JP4722480B2 (ja) 2002-06-07 2003-06-05 糖タンパク質viドメインを含むイムノアドヘシン

Country Status (13)

Country Link
US (1) US7514543B2 (https=)
EP (4) EP1369128A1 (https=)
JP (1) JP4722480B2 (https=)
CN (1) CN1668721B (https=)
AT (1) ATE346095T1 (https=)
AU (2) AU2003250825A1 (https=)
CA (1) CA2488630C (https=)
DE (1) DE60309865T2 (https=)
DK (1) DK1860118T3 (https=)
ES (2) ES2276078T3 (https=)
SI (1) SI1511770T1 (https=)
WO (2) WO2003104282A2 (https=)
ZA (1) ZA200409776B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070071744A1 (en) 2002-06-07 2007-03-29 Gotz Munch Agents which bind to epitopes of glycoprotein VI
EP1369128A1 (en) 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
GB0511590D0 (en) * 2005-06-07 2005-07-13 Procorde Gmbh Anti-thrombotic agents
US7531178B2 (en) 2002-06-07 2009-05-12 Trigen Gmbh Immunoadhesin comprising a glycoprotein VI domain
WO2006061650A2 (en) * 2004-12-10 2006-06-15 Trigen Gmbh Methods, products and uses involving platelets and/or the vasculature
US7645592B2 (en) 2004-04-29 2010-01-12 Otsuka Pharmaceutical Co., Ltd. Glycoprotein VI antibodies and methods of use thereof
KR101194446B1 (ko) 2004-04-29 2012-10-24 오쓰까 세이야꾸 가부시키가이샤 당단백 vi에 특이적인 항체 및 그의 제조방법
ATE548389T1 (de) 2004-08-03 2012-03-15 Innate Pharma Therapeutische und diagnostische verfahren und zusammensetzungen zum targeting von 4ig-b7-h3 und dem entsprechenden nk-zellen-rezeptor
FR2884831B1 (fr) * 2005-04-22 2007-08-10 Merck Sante Soc Par Actions Si Methode de criblage de composes inhibiteurs de la mtp
EP1876240B1 (en) * 2005-04-28 2012-08-22 Mochida Pharmaceutical Co., Ltd. Anti-human platelet membrane glycoprotein vi monoclonal antibody
JP5224707B2 (ja) * 2005-04-28 2013-07-03 持田製薬株式会社 抗血小板膜糖蛋白質viモノクローナル抗体
WO2006117910A1 (ja) 2005-04-28 2006-11-09 Mochida Pharmaceutical Co., Ltd. 抗血小板膜糖蛋白質ⅵモノクローナル抗体
CN101341406A (zh) * 2005-12-22 2009-01-07 盐野义制药株式会社 急性冠状综合征的预后预测方法
SG185307A1 (en) * 2007-10-31 2012-11-29 Otsuka Pharma Co Ltd Uses of a glycoprotein vi (gpvi) inhibitor
ES2569610T3 (es) * 2008-12-04 2016-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Método para producir plaquetas
PL2995315T3 (pl) * 2009-05-15 2024-04-22 University Health Network Kompozycje i sposoby leczenia nowotworów hematologicznych celujące w oddziaływanie sirp alfa-cd47
EP2397495A1 (en) * 2010-06-21 2011-12-21 Sanofi Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof
EP2336188A1 (en) * 2009-12-18 2011-06-22 Sanofi-Aventis Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof
PT2513147T (pt) 2009-12-18 2016-10-11 Sanofi Sa Novos anticorpos antagonistas e seus fragmentos fab contra gpvi e utilizações destes
EP2377888A1 (en) 2010-04-07 2011-10-19 Corimmun GmbH Fusion protein
ES2914814T3 (es) 2012-12-17 2022-06-16 Pf Argentum Ip Holdings Llc Tratamiento de células enfermas CD47+ con fusiones SIRP Alfa-Fc
US20150338330A1 (en) * 2012-12-20 2015-11-26 Fujimori Kogyo Co., Ltd., Method for Comprehensive Assessment of Platelet Aggregation
EP3424957A1 (en) 2017-07-03 2019-01-09 advanceCOR GmbH Fusion protein
CN110964119A (zh) * 2019-12-05 2020-04-07 沣潮医药科技(上海)有限公司 抗疟二聚体免疫粘附素、药物组合物和用途
CN115768784A (zh) * 2020-02-06 2023-03-07 勃林格殷格翰动物保健有限公司 用于检测抗弹状病毒抗体的多肽

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156840A (en) * 1982-03-09 1992-10-20 Cytogen Corporation Amine-containing porphyrin derivatives
ZA887365B (en) 1987-10-02 1990-05-30 Genentech Inc Adheson variants
PT88641B (pt) 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
US5116964A (en) 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
GB9806806D0 (en) 1998-03-30 1998-05-27 Univ Cambridge Tech Peptides and uses thereof
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
GB9810999D0 (en) * 1998-05-21 1998-07-22 Goken Joop Materials and methods relating to the expression of genes
DE60038675T2 (de) 1999-05-07 2009-07-02 Sanofi-Aventis Deutschland Gmbh Rekombinantes plättchenkollagenrezeptorglykoprotein und dessen pharmazeutische verwendung
US6245527B1 (en) * 1999-06-30 2001-06-12 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding glycoprotein VI and recombinant uses thereof
US20040001826A1 (en) 1999-06-30 2004-01-01 Millennium Pharmaceuticals, Inc. Glycoprotein VI and uses thereof
US7291714B1 (en) * 1999-06-30 2007-11-06 Millennium Pharmaceuticals, Inc. Glycoprotein VI and uses thereof
AU7097400A (en) 1999-09-01 2001-03-26 Otsuka Pharmaceutical Co., Ltd. Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof
EP1224942A1 (en) 2001-01-23 2002-07-24 Bernhard Dr. Nieswandt Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases
US7300922B2 (en) 2001-05-25 2007-11-27 Duke University Modulators of pharmacological agents
WO2003008454A2 (en) 2001-07-18 2003-01-30 Merck Patent Gmbh Glycoprotein vi fusion proteins
GB0130543D0 (en) 2001-12-20 2002-02-06 Univ Cambridge Tech Human antibodies and their use
GB0130832D0 (en) 2001-12-22 2002-02-06 Univ Reading Modulation of the activity of the platelet endothelial cell adhesion molecule-1 (pecam-1)
GB0211750D0 (en) 2002-05-22 2002-07-03 Ouwehand Willem Abnormal blood conditions
US7531178B2 (en) 2002-06-07 2009-05-12 Trigen Gmbh Immunoadhesin comprising a glycoprotein VI domain
EP1369128A1 (en) 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
EP1538165A1 (en) 2003-12-03 2005-06-08 Procorde GmbH Inhibitors of glycoprotein VI based on monoclonal antibody hgp 5c4

Similar Documents

Publication Publication Date Title
JP2006512894A5 (https=)
JP3280376B2 (ja) 多価抗原結合性蛋白質
JP6101638B2 (ja) 多価ヘテロマルチマー足場設計及び構築物
US5767260A (en) Antigen-binding fusion proteins
US8431532B2 (en) FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same
KR100280069B1 (ko) 면역글로불린 부분을 갖는 융합 단백질, 이의 제조방법 및 이를포함하는 약제학적 조성물
JP4255618B2 (ja) 単鎖二官能性糖タンパク質ホルモン
CN108112253B (zh) 抗癌融合多肽
JP2003512011A5 (https=)
Utani et al. Laminin chain assembly. Specific sequences at the C terminus of the long arm are required for the formation of specific double-and triple-stranded coiled-coil structures.
JP2016528295A5 (https=)
JP2003501090A5 (https=)
JP2004523205A5 (https=)
AU691607B2 (en) Afamin: a human serum albumin-like protein
RS55609B1 (sr) Fc fuzioni proteini koji sadrže nove linkere ili aranžmane
JP2018515085A (ja) 抗がん融合ポリペプチド
JPH07508178A (ja) レセプター活性化
JP2002500886A5 (https=)
JP2017518748A5 (https=)
JP2010504336A5 (https=)
KR20050007359A (ko) 종양 치료를 위한 면역접합체
KR20200018781A (ko) 반감기 연장 폴리펩티드를 갖는 융합 단백질
JP2002514418A5 (https=)
CN103391787A (zh) uPAR拮抗剂及其应用
JP2008521426A5 (https=)